Literature DB >> 10545170

Crystal structures of the Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase-GMP and -IMP complexes: comparison of purine binding interactions with the XMP complex.

A Héroux1, E L White, L J Ross, D W Borhani.   

Abstract

The crystal structures of the guanosine 5'-monophosphate (GMP) and inosine 5'-monophosphate (IMP) complexes of Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase (HGPRT) have been determined at 1.65 and 1.90 A resolution. These complexes, which crystallize in space groups P2(1) (a = 65.45 A, b = 90.84 A, c = 80. 26 A, and beta = 92.53 degrees ) and P2(1)2(1)2(1) (a = 84.54 A, b = 102.44 A, and c = 108.83 A), each comprise a tetramer in the crystallographic asymmetric unit. All active sites in the tetramers are fully occupied by the nucleotide. Comparison of these structures with that of the xanthosine 5'-monophosphate (XMP)-pyrophosphate-Mg(2+) ternary complex reported in the following article [Héroux, A., et al. (1999) Biochemistry 38, 14495-14506] shows how T. gondii HGPRT is able to recognize guanine, hypoxanthine, and xanthine as substrates, and suggests why the human enzyme cannot use xanthine efficiently. Comparison with the apoenzyme reveals the structural changes that occur upon binding of purines and ribose 5'-phosphate to HGPRT. Two structural features important to the HGPRT mechanism, a previously unrecognized active site loop (loop III', residues 180-184) and an active site peptide bond (Leu78-Lys79) that adopts both the cis and the trans configurations, are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545170     DOI: 10.1021/bi990507q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Pyrophosphate activation in hypoxanthine--guanine phosphoribosyltransferase with transition state analogue.

Authors:  Hua Deng; Robert Callender; Vern L Schramm; Charles Grubmeyer
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

2.  Structure of Salmonella typhimurium OMP synthase in a complete substrate complex.

Authors:  Charles Grubmeyer; Michael Riis Hansen; Alexander A Fedorov; Steven C Almo
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

3.  Functional significance of four successive glycine residues in the pyrophosphate binding loop of fungal 6-oxopurine phosphoribosyltransferases.

Authors:  Lucile Moynié; Marie-France Giraud; Annick Breton; Fanny Boissier; Bertrand Daignan-Fornier; Alain Dautant
Journal:  Protein Sci       Date:  2012-06-11       Impact factor: 6.725

4.  Virtual screening of combinatorial libraries across a gene family: in search of inhibitors of Giardia lamblia guanine phosphoribosyltransferase.

Authors:  A M Aronov; N R Munagala; I D Kuntz; C C Wang
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Structures of hypoxanthine-guanine phosphoribosyltransferase (TTHA0220) from Thermus thermophilus HB8.

Authors:  Mayumi Kanagawa; Seiki Baba; Akio Ebihara; Akeo Shinkai; Ken Hirotsu; Ryosuke Mega; Kwang Kim; Seiki Kuramitsu; Gen-ichi Sampei; Gota Kawai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-27

6.  Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase.

Authors:  David Terán; Dana Hocková; Michal Česnek; Alena Zíková; Lieve Naesens; Dianne T Keough; Luke W Guddat
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

7.  Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase.

Authors:  Paulo S Monzani; Stefano Trapani; Otavio H Thiemann; Glaucius Oliva
Journal:  BMC Struct Biol       Date:  2007-09-25

8.  Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery.

Authors:  Eva Doleželová; David Terán; Ondřej Gahura; Zuzana Kotrbová; Michaela Procházková; Dianne Keough; Petr Špaček; Dana Hocková; Luke Guddat; Alena Zíková
Journal:  PLoS Negl Trop Dis       Date:  2018-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.